RCMI Coordinating Center (RCMI CC) Header Logo

Clayton Yates

TitleDirector for the Center for Biomedical Research
Faculty RankProfessor
InstitutionTuskegee University
DepartmentDepartment of Biology and Center for Cancer Research
Address1200 W Montgomery Rd
Carver Research Building Rm 5
Tuskegee AL 36088
Phone3347278949
vCardDownload vCard

    Collapse Affiliation 
    Collapse groups

    Collapse Research 
    Collapse research activities and funding
    G12MD007585     (YATES, CLAYTON)Jul 7, 1997 - Sep 19, 2017
    NIH
    CENTER FOR BIOMEDICAL RESEARCH
    Role: Co-Principal Investigator
    U54MD007585     (BEDI, DEEPA)Jul 7, 1997 - Mar 31, 2028
    NIH
    Tuskegee University Center for Biomedical Research/ RCMI
    Role: Principal Investigator
    U54CA118948     (MANNE, UPENDER)Sep 23, 2005 - Aug 31, 2026
    NIH
    3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
    Role: Co-Principal Investigator
    U54CA118623     (TURNER, TIMOTHY)Sep 28, 2005 - Aug 31, 2026
    NIH
    2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
    Role: Co-Principal Investigator
    U54CA118638     (RIVERS, BRIAN M.)Sep 29, 2005 - Aug 31, 2026
    NIH
    1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
    Role: Co-Principal Investigator
    R21CA188799     (YATES, CLAYTON)Sep 1, 2014 - Aug 31, 2017
    NIH
    Transcriptional Regulation of Breast Cancer Metastasis within the Tumor Microenvi
    Role: Principal Investigator
    U54CA267746     (FOUAD, MONA N.)Sep 22, 2021 - Aug 31, 2026
    NIH
    UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54)
    Role: Co-Principal Investigator
    OT2CA297504     (YATES, CLAYTON)May 1, 2024 - Apr 30, 2025
    NIH
    Understand the mechanisms through which genetics, biology, and social determinants affect cancer risk and outcomes in diverse populations, to motivate interventions to reduce cancer inequities
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Muhammad A, Hixon JC, Pharmacy Yusuf A, Rivas Zarete JI, Johnson I, Miller J, Adu-Addai B, Yates C, Mahavadi S. Sex-specific epigenetics drive low GPER expression in gastrointestinal smooth muscles in type 2 diabetic mice. Sci Rep. 2024 03 07; 14(1):5633. PMID: 38453938.
      Citations: 1     Fields:    Translation:HumansAnimals
    2. White JA, Kaninjing ET, Adeniji KA, Jibrin P, Obafunwa JO, Ogo CN, Mohammed F, Popoola A, Fatiregun OA, Oluwole OP, Thorpe RJ, Karanam B, Elhussin I, Ambs S, Tang W, Davis M, Polak P, Campbell MJ, Brignole KR, Rotimi SO, Dean-Colomb W, Odedina FT, Yates C. Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways. Prostate. 2024 Apr; 84(5):460-472. PMID: 38192023.
      Citations:    Fields:    Translation:Humans
    3. Gray JS, Wani SA, Hussain S, Huang P, Nayak D, Long MD, Yates C, Clinton SK, Bennet CE, Coss CC, Campbell MJ. The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ER? and AR using a novel ER?-selective ligand alongside Enzalutamide. bioRxiv. 2023 Nov 17. PMID: 38014010.
      Citations:    
    4. Minas TZ, Lord BD, Zhang AL, Candia J, Dorsey TH, Baker FS, Tang W, Bailey-Whyte M, Smith CJ, Obadi OM, Ajao A, Jordan SV, Tettey Y, Biritwum RB, Adjei AA, Mensah JE, Hoover RN, Hsing AW, Liu J, Loffredo CA, Yates C, Cook MB, Ambs S. Circulating trans fatty acids are associated with prostate cancer in Ghanaian and American men. Nat Commun. 2023 07 19; 14(1):4322. PMID: 37468456.
      Citations: 1     Fields:    Translation:Humans
    5. Ghebremedhin A, Salam AB, Adu-Addai B, Noonan S, Stratton R, Ahmed MSU, Khantwal C, Martin GR, Lin H, Andrews C, Karanam B, Rudloff U, Lopez H, Jaynes J, Yates C. A Novel CD206 Targeting Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice. Cells. 2023 04 26; 12(9). PMID: 37174654.
      Citations: 12     Fields:    Translation:Animals
    6. Siddappa M, Hussain S, Wani SA, White J, Tang H, Gray JS, Jafari H, Wu HC, Long MD, Elhussin I, Karanam B, Wang H, Morgan R, Hardiman G, Adelani IB, Rotimi SO, Murphy AR, Nonn L, Davis MB, Kittles RA, Hughes Halbert C, Sucheston-Campbell LE, Yates C, Campbell MJ. African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A. Cancer Res Commun. 2023 04; 3(4):621-639. PMID: 37082578.
      Citations: 7     Fields:    Translation:HumansCells
    7. Parker CC, Bin Salam A, Song PN, Gallegos C, Hunt A, Yates C, Jaynes J, Lopez H, Massicano AVF, Sorace AG, Fernandez S, Houson HA, Lapi SE. Evaluation of a CD206-Targeted Peptide for PET Imaging of Macrophages in Syngeneic Mouse Models of Cancer. Mol Pharm. 2023 05 01; 20(5):2415-2425. PMID: 37014648.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    8. Gobin C, Inkabi S, Lattimore CC, Gu T, Menefee JN, Rodriguez M, Kates H, Fields C, Bian T, Silver N, Xing C, Yates C, Renne R, Xie M, Fredenburg KM. Investigating miR-9 as a mediator in laryngeal cancer health disparities. Front Oncol. 2023; 13:1096882. PMID: 37081981.
      Citations:    
    9. Angajala A, Raymond H, Muhammad A, Uddin Ahmed MS, Haleema S, Haque M, Wang H, Campbell M, Martini R, Karanam B, Kahn AG, Bedi D, Davis M, Tan M, Dean-Colomb W, Yates C. MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans. Sci Rep. 2022 12 22; 12(1):22178. PMID: 36550153.
      Citations: 1     Fields:    Translation:Humans
    10. Hassan M, Trung V, Bedi D, Shaddox S, Gunturu D, Yates C, Datta P, Samuel T. Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD-L1 and MHC I in colon cancer cells. Oncol Lett. 2023 Jan; 25(1):41. PMID: 36589674.
      Citations:    
    11. Hussain S, Yates C, Campbell MJ. Vitamin D and Systems Biology. Nutrients. 2022 Dec 07; 14(24). PMID: 36558356.
      Citations: 5     Fields:    Translation:Humans
    12. Mazumder S, Mitra Ghosh T, Mukherjee UK, Chakravarti S, Amiri F, Waliagha RS, Hemmati F, Mistriotis P, Ahmed S, Elhussin I, Salam AB, Dean-Colomb W, Yates C, Arnold RD, Mitra AK. Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. Cancers (Basel). 2022 Dec 06; 14(23). PMID: 36497496.
      Citations:    
    13. King D, Khodary MG, Samuel T, Yates C, Bedi D. Obesity Influences the Expression of Key Immunomodulators in Normal Human Breast Tissue, Basal-like Breast Cancer Patients, and Cell Lines. Cancers (Basel). 2022 Nov 15; 14(22). PMID: 36428692.
      Citations:    
    14. Elhussin I, Yates C. Ancestry-defined molecular taxonomy of prostate cancer. Trends Cancer. 2022 12; 8(12):973-975. PMID: 36335083.
      Citations:    Fields:    Translation:Humans
    15. White JA, Kaninjing ET, Adeniji KA, Jibrin P, Obafunwa JO, Ogo CN, Mohammed F, Popoola A, Fatiregun OA, Oluwole OP, Karanam B, Elhussin I, Ambs S, Tang W, Davis M, Polak P, Campbell MJ, Brignole KR, Rotimi SO, Dean-Colomb W, Odedina FT, Martin DN, Yates C. Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry. Cancer Res Commun. 2022 09; 2(9):1005-1016. PMID: 36922933.
      Citations: 6     Fields:    Translation:HumansCells
    16. Mori JO, White J, Elhussin I, Duduyemi BM, Karanam B, Yates C, Wang H. Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients. Front Oncol. 2022; 12:928357. PMID: 36033462.
      Citations:    
    17. Husain K, Villalobos-Ayala K, Laverde V, Vazquez OA, Miller B, Kazim S, Blanck G, Hibbs ML, Krystal G, Elhussin I, Mori J, Yates C, Ghansah T. Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer. Cancers (Basel). 2022 Jul 25; 14(15). PMID: 35892872.
      Citations:    
    18. Singhal SK, Byun JS, Yan T, Yancey R, Caban A, Gil Hernandez S, Bufford S, Hewitt SM, Winfield J, Pradhan J, Mustkov V, McDonald JA, P?rez-Stable EJ, N?poles AM, Vohra N, De Siervi A, Yates C, Davis MB, Yang M, Tsai YC, Weissman AM, Gardner K. Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on race. JCI Insight. 2022 07 08; 7(13). PMID: 35639484.
      Citations: 2     Fields:    Translation:HumansCells
    19. Muhammad A, Forcados GE, Katsayal BS, Bako RS, Aminu S, Sadiq IZ, Abubakar MB, Yusuf AP, Malami I, Faruk M, Ibrahim S, Pase PA, Ahmed S, Abubakar IB, Abubakar M, Yates C. Potential epigenetic modifications implicated in triple- to quadruple-negative breast cancer transition: a review. Epigenomics. 2022 06; 14(11):711-726. PMID: 35473304.
      Citations: 5     Fields:    Translation:HumansCells
    20. Minas TZ, Candia J, Dorsey TH, Baker F, Tang W, Kiely M, Smith CJ, Zhang AL, Jordan SV, Obadi OM, Ajao A, Tettey Y, Biritwum RB, Adjei AA, Mensah JE, Hoover RN, Jenkins FJ, Kittles R, Hsing AW, Wang XW, Loffredo CA, Yates C, Cook MB, Ambs S. Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer. Nat Commun. 2022 04 01; 13(1):1759. PMID: 35365620.
      Citations: 7     Fields:    Translation:Humans
    21. Mitchell E, Alese OB, Yates C, Rivers BM, Blackstock W, Newman L, Davis M, Byrd G, Harris AE. Cancer healthcare disparities among African Americans in the United States. J Natl Med Assoc. 2022 Jun; 114(3):236-250. PMID: 35321808.
      Citations: 15     Fields:    Translation:Humans
    22. Kiely M, Milne GL, Minas TZ, Dorsey TH, Tang W, Smith CJ, Baker F, Loffredo CA, Yates C, Cook MB, Ambs S. Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men. J Natl Cancer Inst. 2022 01 11; 114(1):123-129. PMID: 34264335.
      Citations: 9     Fields:    Translation:Humans
    23. Mitra Ghosh T, White J, Davis J, Mazumder S, Kansom T, Skarupa E, Barnett GS, Piazza GA, Bird RC, Mitra AK, Yates C, Cummings BS, Arnold RD. Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer. Front Pharmacol. 2021; 12:736951. PMID: 34938177.
      Citations:    
    24. Wang Y, Liu S, Yang Z, Algazi AP, Lomeli SH, Wang Y, Othus M, Hong A, Wang X, Randolph CE, Jones AM, Bosenberg MW, Byrum SD, Tackett AJ, Lopez H, Yates C, Solit DB, Ribas A, Piva M, Moriceau G, Lo RS. Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy. Cancer Cell. 2021 10 11; 39(10):1375-1387.e6. PMID: 34416167.
      Citations: 49     Fields:    Translation:HumansAnimals
    25. Kiely M, Milne GL, Minas TZ, Dorsey TH, Tang W, Smith CJ, Baker F, Loffredo CA, Yates C, Cook MB, Ambs S. Urinary PGE-M in Men with Prostate Cancer. Cancers (Basel). 2021 Aug 13; 13(16). PMID: 34439226.
      Citations:    
    26. Martini R, Chen Y, Jenkins BD, Elhussin IA, Cheng E, Hoda SA, Ginter PS, Hanover J, Zeidan RB, Oppong JK, Adjei EK, Jibril A, Chitale D, Bensenhaver JM, Awuah B, Bekele M, Abebe E, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Nathansan SD, Jackson L, Jiagge E, Petersen LF, Proctor E, Nikolinakos P, Gyan KK, Yates C, Kittles R, Newman LA, Davis MB. Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort. Sci Rep. 2021 04 29; 11(1):9247. PMID: 33927264.
      Citations: 6     Fields:    Translation:Humans
    27. Saleh M, Chandrashekar DS, Shahin S, Agarwal S, Kim HG, Behring M, Shaikh AJ, Moloo Z, Eltoum IA, Yates C, Varambally S, Manne U. Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women. Transl Oncol. 2021 Jul; 14(7):101086. PMID: 33839593.
      Citations:    
    28. Davenport ML, Echols JB, Silva AD, Anderson JC, Owens P, Yates C, Wei Q, Harada S, Hurst DR, Edmonds MD. miR-31 Displays Subtype Specificity in Lung Cancer. Cancer Res. 2021 04 15; 81(8):1942-1953. PMID: 33558335.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    29. Singhal SK, Byun JS, Park S, Yan T, Yancey R, Caban A, Hernandez SG, Hewitt SM, Boisvert H, Hennek S, Bobrow M, Ahmed MSU, White J, Yates C, Aukerman A, Vanguri R, Bareja R, Lenci R, Farr? PL, De Siervi A, N?poles AM, Vohra N, Gardner K. Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survival. Commun Biol. 2021 02 01; 4(1):150. PMID: 33526872.
      Citations:    
    30. Ghebremedhin A, Salam AB, Adu-Addai B, Noonan S, Stratton R, Ahmed MSU, Khantwal C, Martin GR, Lin H, Andrews C, Karanam B, Rudloff U, Lopez H, Jaynes J, Yates C. A Novel CD206 Targeting Peptide Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice. bioRxiv. 2020 Jul 29. PMID: 32766584.
      Citations:    
    31. Davis M, Martini R, Newman L, Elemento O, White J, Verma A, Datta I, Adrianto I, Chen Y, Gardner K, Kim HG, Colomb WD, Eltoum IE, Frost AR, Grizzle WE, Sboner A, Manne U, Yates C. Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations. Cancers (Basel). 2020 May 13; 12(5). PMID: 32414099.
      Citations:    
    32. O'Neill MJ, Chan K, Jaynes JM, Knotts Z, Xu X, Abisoye-Ogunniyan A, Guerin T, Schlomer J, Li D, Cary JW, Rajasekaran K, Yates C, Kozlov S, Andresson T, Rudloff U. LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies. J Pharm Biomed Anal. 2020 Mar 20; 181:113093. PMID: 31931447.
      Citations: 1     Fields:    Translation:Animals
    33. Locke JE, Reed RD, Kumar V, Berry B, Hendricks D, Carter A, Shelton BA, Mustian MN, MacLennan PA, Qu H, Hannon L, Yates C, Hanaway MJ. Enhanced Advocacy and Health Systems Training Through Patient Navigation Increases Access to Living-donor Kidney Transplantation. Transplantation. 2020 01; 104(1):122-129. PMID: 30946213.
      Citations: 12     Fields:    Translation:Humans
    34. Reed RD, Hites L, Mustian MN, Shelton BA, Hendricks D, Berry B, MacLennan PA, Blackburn J, Wingate MS, Yates C, Hannon L, Kilgore ML, Locke JE. A Qualitative Assessment of the Living Donor Navigator Program to Identify Core Competencies and Promising Practices for Implementation. Prog Transplant. 2020 03; 30(1):29-37. PMID: 31838948.
      Citations: 2     Fields:    Translation:Humans
    35. Ntiamoah P, Monu NR, Abdulkareem FB, Adeniji KA, Obafunwa JO, Komolafe AO, Yates C, Kaninjing E, Carpten JD, Salhia B, Odedina FT, Edelweiss M, Kingham TP, Alatise OI. Pathology Services in Nigeria: Cross-Sectional Survey Results From Three Cancer Consortia. J Glob Oncol. 2019 09; 5:1-9. PMID: 31479341.
      Citations: 3     Fields:    Translation:Humans
    36. Jenkins BD, Martini RN, Hire R, Brown A, Bennett B, Brown I, Howerth EW, Egan M, Hodgson J, Yates C, Kittles R, Chitale D, Ali H, Nathanson D, Nikolinakos P, Newman L, Monteil M, Davis MB. Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):690-700. PMID: 30944146.
      Citations: 24     Fields:    Translation:HumansCells
    37. Ofili EO, Tchounwou PB, Fernandez-Repollet E, Yanagihara R, Akintobi TH, Lee JE, Malouhi M, Garner ST, Hayes TT, Baker AR, Dent AL, Abdelrahim M, Rollins L, Chang SP, Sy A, Hernandez BY, Bullard PL, Noel RJ, Shiramizu B, Hedges JR, Berry MJ, Bond VC, Lima MF, Mokuau N, Kirken RA, Cruz-Correa M, Sarpong DF, Vadgama J, Yates C, Kahn SA, Soliman KF, Perry G, Pezzano M, Luciano CA, Barnett ME, Oyekan A, Kumar D, Norris KC. The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research. Ethn Dis. 2019; 29(Suppl 1):135-144. PMID: 30906162.
      Citations: 16     Fields:    Translation:Humans
    38. Angajala A, Mothershed E, Davis MB, Tripathi S, He Q, Bedi D, Dean-Colomb W, Yates C. Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer. Transl Oncol. 2019 Mar; 12(3):493-501. PMID: 30594038.
      Citations:    
    39. Jones KM, Karanam B, Jones-Triche J, Sandey M, Henderson HJ, Samant RS, Temesgen S, Yates C, Bedi D. Phage Ligands for Identification of Mesenchymal-Like Breast Cancer Cells and Cancer-Associated Fibroblasts. Front Oncol. 2018; 8:625. PMID: 30619759.
      Citations:    
    40. Pierre CC, Hercules SM, Yates C, Daniel JM. Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in Cancer. Biochim Biophys Acta Rev Cancer. 2019 01; 1871(1):64-74. PMID: 30419310.
      Citations: 17     Fields:    Translation:HumansAnimals
    41. Angajala A, Lim S, Phillips JB, Kim JH, Yates C, You Z, Tan M. Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism. Front Immunol. 2018; 9:1605. PMID: 30050539.
      Citations: 166     Fields:    
    42. Mukherjee A, Hollern DP, Williams OG, Rayburn TS, Byrd WA, Yates C, Jones JD. A Review of FOXI3 Regulation of Development and Possible Roles in Cancer Progression and Metastasis. Front Cell Dev Biol. 2018; 6:69. PMID: 30018953.
      Citations:    
    43. Davis M, Tripathi S, Hughley R, He Q, Bae S, Karanam B, Martini R, Newman L, Colomb W, Grizzle W, Yates C. AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature. PLoS One. 2018; 13(6):e0196909. PMID: 29912871.
      Citations: 35     Fields:    Translation:HumansCTClinical Trials
    44. Abisoye-Ogunniyan A, Lin H, Ghebremedhin A, Salam AB, Karanam B, Theodore S, Jones-Trich J, Davis M, Grizzle W, Wang H, Yates C. Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c. Cancer Lett. 2018 09 01; 431:1-10. PMID: 29751044.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    45. Henderson HJ, Karanam B, Samant R, Vig K, Singh SR, Yates C, Bedi D. Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival. PLoS One. 2017; 12(12):e0189662. PMID: 29244827.
      Citations: 6     Fields:    Translation:HumansCells
    46. Woods-Burnham L, Basu A, Cajigas-Du Ross CK, Love A, Yates C, De Leon M, Roy S, Casiano CA. The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models. Prostate. 2017 Dec; 77(16):1601-1608. PMID: 29030865.
      Citations: 11     Fields:    Translation:HumansCells
    47. Ahmed MSU, Salam AB, Yates C, Willian K, Jaynes J, Turner T, Abdalla MO. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer. Int J Nanomedicine. 2017; 12:6973-6984. PMID: 29033565.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    48. Myers JS, Vallega KA, White J, Yu K, Yates CC, Sang QA. Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins. BMC Cancer. 2017 Jul 11; 17(1):480. PMID: 28697756.
      Citations: 3     Fields:    Translation:HumansCells
    49. Yates C, Long MD, Campbell MJ, Sucheston-Campbell L. miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men. Front Biosci (Landmark Ed). 2017 01 01; 22(2):212-229. PMID: 27814612.
      Citations: 9     Fields:    Translation:HumansCells
    50. Sanchez TW, Zhang G, Li J, Dai L, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang JY, Casiano CA. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins. Mol Cell Proteomics. 2016 Dec; 15(12):3564-3580. PMID: 27742740.
      Citations: 16     Fields:    Translation:HumansCells
    51. Jones J, Mukherjee A, Karanam B, Davis M, Jaynes J, Reams RR, Dean-Colomb W, Yates C. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. Cancer Lett. 2016 10 01; 380(2):513-522. PMID: 27424525.
      Citations: 11     Fields:    Translation:Humans
    52. Wang H, Liu W, Black S, Turner O, Daniel JM, Dean-Colomb W, He QP, Davis M, Yates C. Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression. Oncotarget. 2016 Feb 02; 7(5):5677-89. PMID: 26734997.
      Citations: 29     Fields:    Translation:HumansCells
    53. Pierre CC, Longo J, Mavor M, Milosavljevic SB, Chaudhary R, Gilbreath E, Yates C, Daniel JM. Kaiso overexpression promotes intestinal inflammation and potentiates intestinal tumorigenesis in Apc(Min/+) mice. Biochim Biophys Acta. 2015 Sep; 1852(9):1846-55. PMID: 26073433.
      Citations: 16     Fields:    
    54. Reams RR, Jones-Triche J, Chan OT, Hernandez BY, Soliman KF, Yates C. Immunohistological analysis of ABCD3 expression in Caucasian and African American prostate tumors. Biomed Res Int. 2015; 2015:132981. PMID: 25802834.
      Citations: 7     Fields:    Translation:Humans
    55. Arora R, Schmitt D, Karanam B, Tan M, Yates C, Dean-Colomb W. Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers. Oncotarget. 2015 Jan 20; 6(2):662-78. PMID: 25575825.
      Citations: 30     Fields:    Translation:HumansCells
    56. Madan J, Gundala SR, Baruah B, Nagaraju M, Yates C, Turner T, Rangari V, Hamelberg D, Reid MD, Aneja R. Cyclodextrin complexes of reduced bromonoscapine in guar gum microspheres enhance colonic drug delivery. Mol Pharm. 2014 Dec 01; 11(12):4339-49. PMID: 25350222.
      Citations: 6     Fields:    Translation:HumansCells
    57. Smith BN, Burton LJ, Henderson V, Randle DD, Morton DJ, Smith BA, Taliaferro-Smith L, Nagappan P, Yates C, Zayzafoon M, Chung LW, Odero-Marah VA. Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2. PLoS One. 2014; 9(8):e104987. PMID: 25122124.
      Citations: 52     Fields:    Translation:HumansAnimalsCells
    58. Theodore SC, Davis M, Zhao F, Wang H, Chen D, Rhim J, Dean-Colomb W, Turner T, Ji W, Zeng G, Grizzle W, Yates C. MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1. Oncotarget. 2014 Jun 15; 5(11):3512-25. PMID: 25004396.
      Citations: 38     Fields:    Translation:HumansCells
    59. Arora R, Yates C, Gary BD, McClellan S, Tan M, Xi Y, Reed E, Piazza GA, Owen LB, Dean-Colomb W. Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer. PLoS One. 2014; 9(6):e98370. PMID: 24896091.
      Citations: 35     Fields:    Translation:HumansCells
    60. Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb W, Welch DR, Grizzle W, Yates C. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clin Exp Metastasis. 2014 Jun; 31(5):497-510. PMID: 24570268.
      Citations: 30     Fields:    Translation:HumansCells
    61. Jones J, Grizzle W, Wang H, Yates C. MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans. Biotech Histochem. 2013 Oct; 88(7):410-24. PMID: 23901944.
      Citations: 12     Fields:    Translation:Humans
    62. Zhou J, Feigenbaum L, Yee C, Song H, Yates C. Mouse prostate epithelial luminal cells lineage originate in the basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells. Biomed Res Int. 2013; 2013:913179. PMID: 23819124.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    63. Jones J, Wang H, Zhou J, Hardy S, Turner T, Austin D, He Q, Wells A, Grizzle WE, Yates C. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells. Am J Pathol. 2012 Nov; 181(5):1836-46. PMID: 22974583.
      Citations: 39     Fields:    Translation:HumansCells
    64. Cerwinka WH, Sharp SM, Boyan BD, Zhau HE, Chung LW, Yates C. Differentiation of human mesenchymal stem cell spheroids under microgravity conditions. Cell Regen. 2012; 1(1):2. PMID: 25408865.
      Citations:    
    65. Karna P, Rida PC, Turaga RC, Gao J, Gupta M, Fritz A, Werner E, Yates C, Zhou J, Aneja R. A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1a axis and disrupting cell polarity and migration. Carcinogenesis. 2012 Sep; 33(9):1769-81. PMID: 22678119.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    66. Madan J, Baruah B, Nagaraju M, Abdalla MO, Yates C, Turner T, Rangari V, Hamelberg D, Aneja R. Molecular cycloencapsulation augments solubility and improves therapeutic index of brominated noscapine in prostate cancer cells. Mol Pharm. 2012 May 07; 9(5):1470-80. PMID: 22540277.
      Citations: 10     Fields:    Translation:HumansCells
    67. Wang H, Jones J, Turner T, He QP, Hardy S, Grizzle WE, Welch DR, Yates C. Clinical and biological significance of KISS1 expression in prostate cancer. Am J Pathol. 2012 Mar; 180(3):1170-1178. PMID: 22226740.
      Citations: 17     Fields:    Translation:Humans
    68. Karna P, Gundala SR, Gupta MV, Shamsi SA, Pace RD, Yates C, Narayan S, Aneja R. Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo. Carcinogenesis. 2011 Dec; 32(12):1872-80. PMID: 21948980.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    69. Reams RR, Kalari KR, Wang H, Odedina FT, Soliman KF, Yates C. Detecting gene-gene interactions in prostate disease in African American men. Infect Agent Cancer. 2011 Sep 23; 6 Suppl 2:S1. PMID: 21992608.
      Citations:    
    70. Zhou J, Wang H, Cannon V, Wolcott KM, Song H, Yates C. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells. Mol Cancer. 2011 Sep 14; 10:112. PMID: 21917149.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    71. Josson S, Anderson CS, Sung SY, Johnstone PA, Kubo H, Hsieh CL, Arnold R, Gururajan M, Yates C, Chung LW. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate. 2011 Feb 15; 71(3):232-40. PMID: 20672324.
      Citations: 28     Fields:    Translation:HumansCells
    72. Yates C. Prostate tumor cell plasticity: a consequence of the microenvironment. Adv Exp Med Biol. 2011; 720:81-90. PMID: 21901620.
      Citations: 9     Fields:    Translation:HumansCells
    73. Theodore S, Sharp S, Zhou J, Turner T, Li H, Miki J, Ji Y, Patel V, Yates C, Rhim JS. Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient. Int J Oncol. 2010 Dec; 37(6):1477-82. PMID: 21042716.
      Citations: 34     Fields:    Translation:HumansAnimalsCells
    74. Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy. J Control Release. 2011 Feb 10; 149(3):314-22. PMID: 21047537.
      Citations: 31     Fields:    Translation:HumansCells
    75. Yates C, Sharp S, Jones J, Topps D, Coleman M, Aneja R, Jaynes J, Turner T. LHRH-conjugated lytic peptides directly target prostate cancer cells. Biochem Pharmacol. 2011 Jan 01; 81(1):104-10. PMID: 20869347.
      Citations: 7     Fields:    Translation:HumansCells
    76. Josson S, Sharp S, Sung SY, Johnstone PA, Aneja R, Wang R, Gururajan M, Turner T, Chung LW, Yates C. Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells. J Oncol. 2010; 2010. PMID: 20798867.
      Citations:    
    77. Aneja R, Miyagi T, Karna P, Ezell T, Shukla D, Vij Gupta M, Yates C, Chinni SR, Zhau H, Chung LW, Joshi HC. A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells. Eur J Cancer. 2010 Jun; 46(9):1668-78. PMID: 20303260.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    78. Theodore SC, Rhim JS, Turner T, Yates C. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. Ethn Dis. 2010; 20(1 Suppl 1):S1-96-100. PMID: 20521394.
      Citations: 31     Fields:    Translation:HumansCells
    79. Abdalla MO, Aneja R, Dean D, Rangari V, Russell A, Jaynes J, Yates C, Turner T. Synthesis and characterization of noscapine loaded magnetic polymeric nanoparticles. J Magn Magn Mater. 2010 Jan 01; 322(2):190-196. PMID: 20161408.
      Citations:    
    80. Karna P, Sharp SM, Yates C, Prakash S, Aneja R. EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells. Mol Cancer. 2009 Oct 30; 8:93. PMID: 19878573.
      Citations: 16     Fields:    Translation:HumansCells
    81. Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis. 2008; 25(6):621-8. PMID: 18600305.
      Citations: 153     Fields:    Translation:HumansAnimalsCells
    82. Aneja R, Liu M, Yates C, Gao J, Dong X, Zhou B, Vangapandu SN, Zhou J, Joshi HC. Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent. Cancer Res. 2008 Mar 01; 68(5):1495-503. PMID: 18316614.
      Citations: 21     Fields:    Translation:AnimalsCells
    83. Yates CC, Shepard CR, Stolz DB, Wells A. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer. 2007 Apr 23; 96(8):1246-52. PMID: 17406365.
      Citations: 70     Fields:    Translation:HumansAnimalsCells
    84. Yates C, Shepard CR, Papworth G, Dash A, Beer Stolz D, Tannenbaum S, Griffith L, Wells A. Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res. 2007; 97:225-46. PMID: 17419948.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    85. Yates C, Wells A, Turner T. Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br J Cancer. 2005 Jan 31; 92(2):366-75. PMID: 15655536.
      Citations: 16     Fields:    Translation:HumansCells
    Yates's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (304)
    Explore
    _
    Co-Authors (41)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support